Trelagliptin-13Cd3 succinate

SL-11746

Trelagliptin-13Cd3 succinate, >98%

Synonyms : SYR-472 -13Cd3 succinate; Zafatek-13Cd3

IUPAC Name : (R)-2-((6-(3-Aminopiperidin-1-yl)-3-(methyl-13C-d3)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile succinate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Trelagliptin-13Cd3 succinate is a double-labelled version of Trelagliptin succinate. This can be used as an analytical labelled reference standard. Trelagliptin succinate is a long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

References : Flick C. A. et al.: J. Med. Chem., 60(15), 6480-6515, 2017.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.